Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Yael Hirsch-Moverman

Datos Biográficos

ID90462
NOMBREYael Hirsch-Moverman
NOMBRESYael
APELLIDOHirsch-Moverman
FIRMAHIRSCH-MOVERMAN Y
VERIFICADONo
TOTAL DE OBRAS3
TOTAL DE CITAS0
TOTAL COMO AUTOR3
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2016
AÑO MÁS RECIENTE DE PUBLICACIÓN2024
ÍNDICE H0
  • Vaccine Hesitancy at Nine Community Sites Across the United States, Early in Covid-19 Vaccine Rollout

    Open Access•Aneeka Ratnayake, Julie H Hernandez et al.•ARTICLE•Journal of Racial and Ethnic…•2024•Referencias: 46

    Background Vaccine hesitancy has been a significant concern throughout the COVID-19 pandemic. Vaccine hesitancy can be attributed to lack of confidence in vaccines, complacency about the health threat, or lack of convenience of vaccination. To date, few studies have used methods designed to include populations underrepresented in research when identifying factors associated with vaccine hesitancy. Methods Between January and July 2021, potential …

  • Prevalence, patterns, and correlates of HIV disclosure among TB-HIV patients initiating antiretroviral therapy in Lesotho

    Eleanor Hayes-Larson, Yael Hirsch-Moverman et al.•ARTICLE•AIDS Care•2017

    Disclosure of HIV-positive status has important implications for patient outcomes and preventing HIV transmission, but has been understudied in TB-HIV patients. We assessed disclosure patterns and correlates of non-disclosure among adult TB-HIV patients initiating ART enrolled in the START Study, a mixed-methods cluster-randomized trial conducted in Lesotho, which evaluated a combination intervention package (CIP) versus standard of care. Intervi…

  • The START Study to evaluate the effectiveness of a combination intervention package to enhance antiretroviral therapy uptake and retention during TB treatment among TB/HIV patients in Lesotho

    Open Access•Andrea A Howard, Yael Hirsch-Moverman et al.•ARTICLE•Global Health Action•2016

    BACKGROUND: Initiating antiretroviral therapy (ART) early during tuberculosis (TB) treatment increases survival; however, implementation is suboptimal. Implementation science studies are needed to identify interventions to address this evidence-to-program gap. OBJECTIVE: The Start TB Patients on ART and Retain on Treatment (START) Study is a mixed-methods, cluster-randomized trial aimed at evaluating the effectiveness, cost-effectiveness, and acc…

Sin obras prominentes en esta página.

  • The START Study to evaluate the effectiveness of a combination intervention package to enhance antiretroviral therapy uptake and retention during TB treatment among TB/HIV patients in Lesotho

    Open Access•Andrea A Howard, Yael Hirsch-Moverman et al.•ARTICLE•Global Health Action•2016

    BACKGROUND: Initiating antiretroviral therapy (ART) early during tuberculosis (TB) treatment increases survival; however, implementation is suboptimal. Implementation science studies are needed to identify interventions to address this evidence-to-program gap. OBJECTIVE: The Start TB Patients on ART and Retain on Treatment (START) Study is a mixed-methods, cluster-randomized trial aimed at evaluating the effectiveness, cost-effectiveness, and acc…

  • Prevalence, patterns, and correlates of HIV disclosure among TB-HIV patients initiating antiretroviral therapy in Lesotho

    Eleanor Hayes-Larson, Yael Hirsch-Moverman et al.•ARTICLE•AIDS Care•2017

    Disclosure of HIV-positive status has important implications for patient outcomes and preventing HIV transmission, but has been understudied in TB-HIV patients. We assessed disclosure patterns and correlates of non-disclosure among adult TB-HIV patients initiating ART enrolled in the START Study, a mixed-methods cluster-randomized trial conducted in Lesotho, which evaluated a combination intervention package (CIP) versus standard of care. Intervi…

  • Vaccine Hesitancy at Nine Community Sites Across the United States, Early in Covid-19 Vaccine Rollout

    Open Access•Aneeka Ratnayake, Julie H Hernandez et al.•ARTICLE•Journal of Racial and Ethnic…•2024•Referencias: 46

    Background Vaccine hesitancy has been a significant concern throughout the COVID-19 pandemic. Vaccine hesitancy can be attributed to lack of confidence in vaccines, complacency about the health threat, or lack of convenience of vaccination. To date, few studies have used methods designed to include populations underrepresented in research when identifying factors associated with vaccine hesitancy. Methods Between January and July 2021, potential …

Family medicine (3 obras) · Medicine (3 obras) · Demography (2 obras) · Environmental health (2 obras) · HIV/AIDS Research and Interventions (2 obras) · Internal Medicine (2 obras) · Nursing (2 obras) · Pneumocystis jirovecii pneumonia detection and treatment (2 obras) · Population (2 obras) · Cohort (1 obras)

Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae